Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
Open Access
- 28 January 2022
- journal article
- research article
- Published by Elsevier in SSM - Qualitative Research in Health
- Vol. 2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- “When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient RetentionPLOS ONE, 2016
- Adverse Events Associated With the Treatment of Multidrug-Resistant TuberculosisAmerican Journal of Therapeutics, 2016
- Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in IndiaPLOS ONE, 2015
- Investing in Justice: Ethics, Evidence, and the Eradication Investment Cases for Lymphatic Filariasis and OnchocerciasisAmerican Journal of Public Health, 2015
- Alcohol, Hospital Discharge, and Socioeconomic Risk Factors for Default from Multidrug Resistant Tuberculosis Treatment in Rural South Africa: A Retrospective Cohort StudyPLOS ONE, 2013
- ‘I cry every day’: experiences of patients co‐infected with HIV and multidrug‐resistant tuberculosisTropical Medicine & International Health, 2013
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateEuropean Respiratory Journal, 2011
- What's in a name? Qualitative description revisitedResearch in Nursing & Health, 2009
- Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative ResearchPLOS Medicine, 2007
- Whatever happened to qualitative description?Research in Nursing & Health, 2000